PET imaging as a tool for assessing COVID-19 brain changes
| dc.creator | Fontana, Igor C. | |
| dc.creator | Bongarzone, Salvatore | |
| dc.creator | Gee, Antony | |
| dc.creator | Souza, Diogo O. | |
| dc.creator | Zimmer, Eduardo R. | |
| dc.date.accessioned | 2020-11-03T18:18:18Z | |
| dc.date.available | 2020-11-03T18:18:18Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection. | pt_BR |
| dc.identifier.citation | FONTANA, I. C. et al. PET imaging as a tool for assessing COVID-19 brain changes. Trends in Neurosciences, [S.l.], 2020. No prelo. | pt_BR |
| dc.identifier.uri | https://repositorio.ufla.br/handle/1/43606 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0166223620302435 | pt_BR |
| dc.language | en_US | pt_BR |
| dc.publisher | Elsevier | pt_BR |
| dc.rights | openAccess | pt_BR |
| dc.source | Trends in Neurosciences | pt_BR |
| dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | pt_BR |
| dc.subject | COVID-19 - Neurological manifestations | pt_BR |
| dc.subject | Positron Emission Tomography (PET) radiotracers | pt_BR |
| dc.title | PET imaging as a tool for assessing COVID-19 brain changes | pt_BR |
| dc.type | Artigo | pt_BR |
Arquivos
Licença do pacote
1 - 1 de 1
Carregando...
- Nome:
- license.txt
- Tamanho:
- 953 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
